Mortality and morbidity reduction with Candesartan in patients with chronic heart failure and left ventricular systolic dysfunction: results of the CHARM low-left ventricular ejection fraction trials (Q45113230)
Jump to navigation
Jump to search
scientific article published on 18 October 2004
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Mortality and morbidity reduction with Candesartan in patients with chronic heart failure and left ventricular systolic dysfunction: results of the CHARM low-left ventricular ejection fraction trials |
scientific article published on 18 October 2004 |
Statements
1 reference
Mortality and morbidity reduction with Candesartan in patients with chronic heart failure and left ventricular systolic dysfunction: results of the CHARM low-left ventricular ejection fraction trials (English)
1 reference
1 reference
Christopher B Granger
1 reference
Alain Cohen-Solal
1 reference
Karl Swedberg
1 reference
Salim Yusuf
1 reference
John J V McMurray
1 reference
Marc A Pfeffer
1 reference
Robert S McKelvie
1 reference
Eric L Michelson
1 reference
Peter Held
1 reference
Jeffrey L Probstfield
1 reference
Mark E Dunlap
1 reference
Jerzy Kuch
1 reference
James B Young
1 reference
Rainer Dietz
1 reference
Bertil Olofsson
1 reference
Jan Ostergren
1 reference
Scott D Solomon
1 reference
Candesartan in Heart failure Assessment of Reduction in Mortality and morbidity (CHARM) Investigators and Committees
1 reference
18 October 2004
1 reference
1 reference
110
1 reference
17
1 reference
2618-2626
1 reference
Identifiers
1 reference
1 reference